Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 81469-492

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 81469-492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by First Nation Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (04436591 Edfc 44f9 9813 Cf04136c727a 01)

Chemical structure of divalproex sodium, depicting its molecular composition with sodium ion and branched alkyl groups.*

FDA Label Image

Figure (04436591 Edfc 44f9 9813 Cf04136c727a 02)

A line graph comparing the percentage reduction in CPS rate between divalproex sodium and placebo across a patient population. The x-axis shows the percentage of patients, while the y-axis represents the percent reduction in CPS rate, ranging from -100% to 100%. The graph illustrates improvement and worsening regions with divalproex sodium showing a higher rate of improvement compared to placebo.*

FDA Label Image

Figure2 (04436591 Edfc 44f9 9813 Cf04136c727a 03)

A line chart depicting the percentage reduction in CPS rate versus the percentage of patients in a study. The chart compares two groups: High Dose (solid line) and Low Dose (dashed line). The vertical axis shows percentage reduction from -100% to 100%, labeled with improvement, no change, and worsening, while the horizontal axis displays percentage of patients from 0 to 100.*

FDA Label Image

100's Pack (04436591 Edfc 44f9 9813 Cf04136c727a 04)

Label for Divalproex Sodium Delayed-Release Capsules, USP 125 mg by First Nation Group, LLC. The label indicates 100 capsules of coated pellets for oral use. It includes instructions to dispense the medication guide separately, storage conditions, and manufacturer information. The packaging also features a barcode and QR code for the medication guide.*

FDA Label Image

1000's Pack (04436591 Edfc 44f9 9813 Cf04136c727a 05)

The packaging label for Divalproex Sodium Delayed-Release Capsules, USP, 125 mg strength. The cobalt blue to light blue transparent capsule is coated pellets in an oral dosage form. The label indicates each package contains 1000 capsules. Manufactured for First Nation Group, LLC, the label includes storage instructions, handling precautions, and a website link for the medication guide.*

FDA Label Image

Image (04436591 Edfc 44f9 9813 Cf04136c727a 187 2)

Image shows a single coated pellet capsule marked with 'LS 447'. This corresponds to divalproex sodium 125 mg coated pellet capsules manufactured by First Nation Group, LLC, NDC 81469-492. The capsule is visible on a gray and white background.*

FDA Label Image

Image (04436591 Edfc 44f9 9813 Cf04136c727a 187 3)

An instructional illustration showing the twisting motion required to open a safety cap marked with "LS" and the number "447". The image directs twisting the cap counterclockwise to unlock or remove it.*

FDA Label Image

Image (04436591 Edfc 44f9 9813 Cf04136c727a 187 4)

An illustration showing a hand pouring small, spherical coated pellets from a container labeled "LS" into an open mouth. The image visually represents the contents of a coated pellet capsule, consistent with the oral dosage form of divalproex sodium capsules.*

FDA Label Image

Image (04436591 Edfc 44f9 9813 Cf04136c727a 187 5)

An illustration showing a person opening their mouth to receive medicine administered by spoon, depicting oral administration typically used for liquid or semi-solid dosage forms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.